Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Illumina Inc (ILMN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
108.380 -0.500    -0.46%
02:31:14 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US4523271090 
S/N:  927079
  • Volume: 11
  • Bid/Ask: 109.760 / 110.520
  • Day's Range: 108.380 - 108.380
Illumina 108.380 -0.500 -0.46%

Illumina Inc Company Profile

 
Get an in-depth profile of Illumina Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

10615

Equity Type

ORD

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Contact Information

Address 5200 Illumina Way
San Diego, 92122
United States
Phone 858 202 4500
Fax 858 202 4545

Top Executives

Name Age Since Title
Andrew Teno 38 2023 Independent Director
Clement Adebamowo - - Member of Ethics Advisory Board
Leslie G. Biesecker - - Member of Ethics Advisory Board
Freda C. Lewis-Hall 69 - Member of Ethics Advisory Board
Nita Farahany - - Member of Ethics Advisory Board
Charmaine Royal - - Member of Ethics Advisory Board
Glenn Cohen - - Member of Ethics Advisory Board
Scott B. Ullem 57 2023 Independent Director
Stephen P. MacMillan 60 2023 Independent Chairman of the Board
Jacob Thaysen 49 2023 CEO & Director
Robert S. Epstein 69 2012 Independent Director
Philip W. Schiller 64 2016 Independent Director
Frances Hamilton Arnold 67 2016 Independent Director
Gary S. Guthart 58 2017 Independent Director
Caroline D. Dorsa 65 2017 Independent Director
Susan E. Siegel 63 2019 Independent Director
Scott Gottlieb 51 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ILMN Comments

Write your thoughts about Illumina Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Luis Franco
Luis Franco Nov 24, 2023 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There is no way it would go up from here (100)
Vlas Dacian
Vlas Dacian Oct 30, 2023 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
50$ soon
one hung low
one hung low Oct 01, 2022 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get in to this stock before it's too late, it's only trading at P/E Ratio -1,530.59. LOL LOL
Justin Lowery
Justin Lowery May 09, 2022 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like a good buy to throw a little in
prashant patel
Long69 Dec 03, 2021 12:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.bloomberg.com/news/articles/2021-11-29/omicron-tests-biden-s-1-7-billion-plan-to-better-track-variants
kahiru sabit
kahiru sabit Dec 03, 2021 12:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is comante
asdfaf asfsadf
asdfaf asfsadf Nov 10, 2021 3:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should i hold?
mr growth
GrowthFactory Nov 05, 2021 9:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why Illumina corrected after this great earnings?
Paolo Ianna
Paolo Ianna Nov 05, 2021 9:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think for the next EU fine on Grail acquisition
dd dd
dd dd Aug 24, 2021 12:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
IS IT AWEFUL?
Jamshed Ahmed
Jamshed Ahmed Aug 05, 2021 4:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Brandon Son
Brandon Son Apr 27, 2021 1:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should rise on earnings
de baser
de baser Apr 27, 2021 1:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeah "should"
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email